Congress·In Committee·S. 3729
PBM Reporting Transparency Act
Medicare: Study on Pharmacy Middlemen and Drug Costs
Legislative Progress
Senate
Key Points
- This bill, introduced by Mr. Warner and a group of bipartisan senators, requires a deep dive into how "pharmacy benefit managers" work with Medicare. These companies act as middlemen who negotiate drug prices between insurance plans and pharmacies.
- The goal is to find out how secret deals between these middlemen and insurance companies affect what seniors pay out of their own pockets for medicine. It also looks at whether these deals are making it harder for local pharmacies to stay in business by changing how much they get paid.
- An independent advisory group will create two major reports for Congress. These reports will look for trends in drug pricing and provide specific recommendations on how to fix problems that make healthcare more expensive for regular people.
- The first report will be finished about two years after the government provides the necessary data, with a follow-up report two years later. This helps Congress see if drug costs and middleman practices are getting better or worse over time.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
2 milestones2 actions
Jan 29, 2026
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Jan 29, 2026
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
PBM Reporting Transparency Act
Bill NumberS 3729
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.
Data Sources
Sponsor
Cosponsors
(3)D: 1R: 2
Analysis generated by AI. Always verify with official sources.